The Food and Drug Administration approved a controversial knee-surgery device after receiving pressure from lawmakers and lobbyists, the Washington Post reports. According to a report released last week by the FDA, regulators seem to have buckled under political pressure from four New Jersey lawmakers with financial ties to ReGen Biologics. The report noted that FDA staff had previously opposed approval of the device.